Never Miss Important Company Updates Again

Get AI-powered summaries of SEC filings delivered to your inbox

Follow your favorite stocks and get email alerts when they release important updates. Completely free.

Covers 5,000+ public companies

Get started →

Sign up to stay up to date with the stocks you care about

Most recent public disclosures: AI-powered summaries of the latest corporate filings

10051

1

EXAGEN INC. Exagen Inc. Reports Mixed Q3 Results with Revenue Growth and Improved Losses

Via official filing (AI summary) | 6 months ago | 0 comments

10052

1

Volcon, Inc. Volcon Reports Revenue Growth, Net Loss in Q3 2024, Cites Challenges with Manufacturing and Inventory

Via official filing (AI summary) | 6 months ago | 0 comments

10053

1

UNITED GUARDIAN INC United-Guardian Reports 17% Revenue Growth, Improved Profitability in Q3 2024

Via official filing (AI summary) | 6 months ago | 0 comments

10054

1

Great Elm Group, Inc. Great Elm Group Reports 21% Revenue Growth, Net Income Increase in Q3 2024

Via official filing (AI summary) | 6 months ago | 0 comments

10055

1

Plymouth Industrial REIT, Inc. Plymouth Industrial REIT Reports Mixed Q3 Results Amid Challenging Operating Environment

Via official filing (AI summary) | 6 months ago | 0 comments

10056

1

Data Call Technologies Data Call Technologies Reports Decline in Revenues and Net Loss for Q3 2024

Via official filing (AI summary) | 6 months ago | 0 comments

10057

1

CIVISTA BANCSHARES, INC. Civista Bancshares Reports 19.5% Decrease in Net Income, 5.2% Increase in Total Assets in Q3 2024

Via official filing (AI summary) | 6 months ago | 0 comments

10058

1

ATOSSA THERAPEUTICS, INC. Atossa Therapeutics Reports Decrease in Cash and Cash Equivalents, Net Loss in Latest Quarter

Via official filing (AI summary) | 6 months ago | 0 comments

10059

1

CG Oncology, Inc. CG Oncology Reports Significant Financial Growth, Net Loss in Q3 2024

Via official filing (AI summary) | 6 months ago | 0 comments

10060

1

Mereo BioPharma Group plc Mereo BioPharma Reports Net Loss of $15M, Increased Operating Expenses in Q3 2024

Via official filing (AI summary) | 6 months ago | 0 comments

10061

1

ARTELO BIOSCIENCES, INC. Artelo Biosciences Reports Q3 Financial Results, Improved Liquidity, and Reduced Operating Expenses

Via official filing (AI summary) | 6 months ago | 0 comments

10062

1

Indaptus Therapeutics, Inc. Indaptus Therapeutics Reports Decline in Cash and Cash Equivalents, Net Loss in Latest Quarter

Via official filing (AI summary) | 6 months ago | 0 comments

10063

1

Compass Therapeutics, Inc. Compass Therapeutics Reports Financial Results for Nine Months Ended September 30, 2024, with Increased Cash and Licensing Revenue

Via official filing (AI summary) | 6 months ago | 0 comments

10064

1

Advantage Solutions Inc. Advantage Solutions Reports Decline in Financial Performance for Q3 and Nine Months of 2024

Via official filing (AI summary) | 6 months ago | 0 comments

10065

1

Pyxis Oncology, Inc. Pyxis Oncology Reports Revenue Growth, Improved Losses, and Strategic Acquisitions in 9-Month Update

Via official filing (AI summary) | 6 months ago | 0 comments

10066

1

Mill City Ventures III, Ltd Mill City Ventures III, Ltd. Reports Mixed Q3 Results, Significant Improvement in Nine-Month Period

Via official filing (AI summary) | 6 months ago | 0 comments

10067

1

Alight, Inc. / Delaware Alight, Inc. Reports Slight Revenue Decline, Ongoing Profitability Challenges in Q3 2024

Via official filing (AI summary) | 6 months ago | 0 comments

10068

1

OneSolution Technology Inc. OneSolution Technology Reports Improved Financials, Net Income Turnaround in Q2 2024

Via official filing (AI summary) | 6 months ago | 0 comments

10069

1

Shimmick Corp Shimmick Corporation Reports Significant Financial Challenges, Net Losses in Latest Quarter

Via official filing (AI summary) | 6 months ago | 0 comments

10070

1

NV5 Global, Inc. NV5 Global Reports 5.6% Revenue Growth, Gross Profit Margin Increase in Q3 2024

Via official filing (AI summary) | 6 months ago | 0 comments

10071

1

BridgeBio Pharma, Inc. BridgeBio Pharma Reports Q3 2024 Financial Results, Significant Restructuring, and Milestone Payment Opportunity

Via official filing (AI summary) | 6 months ago | 0 comments

10072

1

Absci Corp Absci Corporation Reports 129% Revenue Growth in Q3, Net Loss Widens

Via official filing (AI summary) | 6 months ago | 0 comments

10073

1

Roivant Sciences Ltd. Roivant Sciences Reports Revenue Growth, Increased Expenses, and Net Loss in Latest Quarter

Via official filing (AI summary) | 6 months ago | 0 comments

10074

1

Thoughtworks Holding, Inc. Thoughtworks Reports Decline in Revenue and Net Loss for Q3 and Nine Months of 2024

Via official filing (AI summary) | 6 months ago | 0 comments

10075

1

TScan Therapeutics, Inc. TScan Therapeutics Reports Decline in Collaboration Revenue, Increased Operating Expenses in Q3 2024

Via official filing (AI summary) | 6 months ago | 0 comments